Thank you for visiting the SynSonix Blog. SynSonix is a medical device company, which is developing ultrasonic neuromodulation technology - a platform technology to replace current brain stimulation technologies with a noninvasive alternative, pulsed ultrasound. Our technology will serve as the basis for novel brain disease treatments, as well as for future brain-machine interfaces to be used in various industries. Here, you can keep up with our company activities. For further information, please visit our company website at

Sunday, December 6, 2009

SynSonix Founders Lecture in M.I.T. Neurotechnology Ventures Course

This past week on 12/01, Jamie Tyler and Sumon Pal co-founders of SynSonix presented in the Neurotechnology Ventures course at M.I.T. in Cambridge, MA. In the lecture entitled "Chasing Quanta and Building a Neurotechnology in Tough Economic Times", Tyler advised young neurotechnology entrepreneurs to "stay the course and continue making translational progress through your research and technology development endeavors while we are in a financial landscape, where investments are tough to secure". Drs. Tyler and Pal went on to explain their corporate strategy and outlined how they have been increasing the company valuation and expanding their IP portfolio even in the absence of investment dollars.

For more information about the M.I.T. Neurotechnology Ventures course run by Dr. Ed Boyden and Joost Bonsen please see